George Solomon
Clinical trials sponsored by George Solomon, explained in plain language.
-
New hope for rare CF mutations: personalized drug trial opens
Disease control Recruiting nowThis study tests whether certain drugs (CFTR modulators) that are already approved for some people with cystic fibrosis can help those with less common genetic mutations. About 20 participants aged 6 and older will take these drugs off-label to see if their lung function improves…
Phase: EARLY_PHASE1 • Sponsor: George Solomon • Aim: Disease control
Last updated May 20, 2026 11:57 UTC
-
RARE study aims to unlock treatments for overlooked cystic fibrosis patients
Knowledge-focused Recruiting nowThis study collects blood, nasal, and intestinal cells from 500 people with cystic fibrosis caused by rare gene mutations. The cells are stored and shared with researchers to test potential new drugs in the lab. Participants must be at least 12 years old and have certain rare mut…
Sponsor: George Solomon • Aim: Knowledge-focused
Last updated May 26, 2026 04:27 UTC